Gradient Ventures has made an additional investment in BenchSci, bringing the latter company’s total funding to $20.5 million. Based in Toronto, BenchSci is an AI-assisted antibody selection platform.
Source: Press Release
Gradient Ventures has made an additional investment in BenchSci, bringing the latter company’s total funding to $20.5 million. Based in Toronto, BenchSci is an AI-assisted antibody selection platform.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: